Phase 3 Lung Cancer Trial, Not Yet Recruiting NCT06970782 Sponsor: Avistone Biotechnology Co., Ltd. Condition: Lung Cancer
Back to Lung Cancer

Phase 3 Lung Cancer Trial, Not Yet Recruiting

NCT06970782
Not Yet Recruiting Phase 3

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who are able to understand and are willing to sign a written consent form.
  • People who are at least 18 years old.
  • People who have been diagnosed through a tissue or cell sample with locally advanced or metastatic non-small cell lung cancer (a specific type of lung cancer) at an advanced stage (stage IIIB to IV).
  • People who have at least one area of cancer that can be measured using standard imaging criteria.
  • People whose overall health and ability to carry out daily activities falls within a certain range on a standard scale used by doctors (a score of 0 or 1, meaning fully active or restricted in strenuous activity but able to carry out light work).

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People whose cancer has specific genetic changes known as ALK or ROS1 mutations.
  • People who have brain or central nervous system involvement from their cancer that is causing symptoms or is unstable, or that requires higher doses of steroids to keep under control.
  • People who have not yet recovered from side effects or complications of previous cancer treatments (such as chemotherapy, surgery, or radiotherapy) to a mild or resolved level before joining the trial — exceptions may apply for hair loss and certain permanent radiation-related effects (confirm with trial site).
  • People who have had major surgery or a significant injury within the 4 weeks before starting the trial treatment.
  • People who are pregnant or currently breastfeeding.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 30 July 2026

Contact this trial

Phone: +86-10-84148931

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Phase 3
Sponsor
Avistone Biotechnology Co., Ltd.
Registry
ClinicalTrials.gov
Start date
15 May 2025
Est. completion
31 December 2027

Primary endpoints

Progression-Free Survival (PFS) by BICR

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov